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Abstract
Background: Although diseases associated with microvascular endothelial dysfunction are among the most prevalent
illnesses to date, currently no method exists to isolate pure endothelial cells (EC) from skeletal muscle for in vivo or in vitro
study.
Methodology: By utilizing multicolor fluorescent-activated cell sorting (FACS), we have isolated a distinct population of Sca-
1
+, CD31
+, CD34
dim and CD45
2 cells from skeletal muscles of C57BL6 mice. Characterization of this population revealed
these cells are functional EC that can be expanded several times in culture without losing their phenotype or capabilities to
uptake acetylated low-density lipoprotein (ac-LDL), produce nitric oxide (NO) and form vascular tubes. When transplanted
subcutaneously or intramuscularly into the tibialis anterior muscle, EC formed microvessels and integrated with existing
vasculature.
Conclusion: This method, which is highly reproducible, can be used to study the biology and role of EC in diseases such as
peripheral vascular disease. In addition this method allows us to isolate large quantities of skeletal muscle derived EC with
potential for therapeutic angiogenic applications.
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Introduction
The skeletal muscle is the organ with major microvascular mass
[1]. Consequently there are many diseases associated with
dysfunctional EC and/or microvascular tissue of the skeletal
muscle including atherosclerosis, hypertension, diabetes, obesity,
and peripheral vascular disease (PVD) [2–8]. PVD has become in
recent years one of the most prevalent illnesses among Americans
affecting an estimated 29% of the population older than 70 years
[9]. In addition muscle diseases including muscular dystrophies
and inflammatory diseases are also associated with microvascular
dysfunction of the skeletal muscle [10–13] . Yet the study of
endothelial function in all these diseases associated with micro-
vascular dysfunction in the skeletal muscle has been restricted by
the ability to efficiently characterize and isolate EC in vivo and
expand them in vitro. Nonetheless the phenotype of endothelial
cells from skeletal muscles has not been well characterized.
Furthermore to our knowledge, a procedure that directly isolates
pure populations of endothelial cells (EC) from skeletal muscle
does not presently exist.
In the literature protocols utilizing culture methods, sorting
based on acetylated low-density lipoprotein (ac-LDL) uptake or
expression of CD31 have been described for isolating EC from
non-muscle tissues [14–17]. However, such methods inherently
isolate a heterogeneous population of cells some of which are
endothelial. This is due to the non-specificity of selective culturing
or sorting when utilizing only one marker such as CD31 which is
not solely expressed by EC [18]. Though ac-LDL uptake has
proven valuable in functional assays it is not exclusive to EC but
also a property of macrophages [19]. Despite application in
various tissues, none of these methods have been applied to study
endothelial cells from skeletal muscles.
Here we first characterize the phenotype of EC from skeletal
muscles by staining mouse muscle tissue for Sca-1, CD31 and
CD34. We then used these markers to develop a method utilizing
multicolor flow cytometry to exclusively sort muscle derived
venular, arterial and capillary EC which are all positive for Sca-1,
CD31 and CD34 while excluding hematopoietic cells which express
the common leukocyte antigen CD45. We can FACS-sort these
endothelial cells from mouse skeletal muscles and culture them for
more than 80 days. In culture these muscle EC retain endothelial
functions and upon transplantation demonstrate robust angiogenic
capacity. Thus this technique can be used to study pure populations
of muscle EC and to develop angiogenic therapeutic strategies.
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Immunofluorescent and immunohistochemical Tissue
Staining
To identify the skeletal muscle vascular phenotype, pectoralis,
triceps, tibialis anterior, gastronemous and quadriceps tissue
sections from 6–12 month old (MO) C57BL6 mice fixed with
2% Paraformaldehyde (PFA) were stained for smooth muscle actin
(SMA), Sca-1 and CD34, then costained for CD31. Slides were
also stained with 49,6-Diamidino-2-phenylindole dihydrochloride
(DAPI), purchased from Vector labs (Burlingame, CA). Cy3
conjugated monoclonal anti-SMA antibody (Sigma, St. Louis,
MO) was used at 1:400. Purified polyclonal rat anti-CD34 and
biotinylated polyclonal anti-Sca-1 were purchased from BD
Pharmingen (San Jose CA) and diluted at 1:50 and 1:200. Anti-
rat Alexa 594 (Invitrogen, Carlbad, CA) and Texas Red
conjugated Avidin (BD Pharmingen, San Jose, CA), were diluted
at 1:1000 and 1:500. FITC conjugated anti-CD31 (BD Pharmin-
gen, San Jose CA) was used at 1:50. Prior to staining with the
biotinylated anti-Sca-1, tissue was treated with avidin/biotin block
(Vector Burlingame, CA). All antibodies were diluted in phosphate
buffered saline (PBS)+1% bovine serum albumin (BSA). Controls
with only secondary antibodies were included for all staining
described in this manuscript.
Staining of Freshly FACS-sorted cells on cytospins
Freshly FACS-sorted cells fixed with 2% PFA were cytocen-
trifuged onto microscope slides for 5 minutes at 400 g rcf.
Immunoperoxidase staining was done using a polyclonal rabbit
anti-vWF antibody (Dako, Carpinteria, CA) at a 1:200 dilution
followed by a biotinylated anti-rabbit antibody at 1:200 and
treatment with the Vectastain ABC kit and 3,39-diaminobenzidine
(DAB) substrate kit according to manufacturers protocol (Vector
Burlingame, CA). Avidin/biotin block was administered prior to
staining with the biotinylated anti-rabbit antibody.
Staining of cultured muscle EC
Immunofluoroscence staining of cultured muscle EC was done
using a polyclonal rabbit anti-vWF antibody (Dako, Carpinteria,
CA) at a 1:200 dilution followed by anti-rabbit Alexa 594
conjugated antibody (Invitrogen, Carlbad, CA) at 1:1000.
Polyclonal rabbit anti-eNOS (Abcam, Cambridge MA) was used
at 1:100 followed by anti-rabbit Alexa 647 antibody (Invitrogen,
Carlbad, CA) at a 1:800 dilution. Cells were also stained with
DAPI to visualize the nuclei.
Staining of transplanted tissues
Tissue sections were fixed with 2% PFA and stained separately
for vWF, CD31 and SMA then co-stained with DAPI. Anti-vWF
was used as previously described butfollowed with anti-rabbit Alexa
647 antibody (Invitrogen, Carlbad, CA) diluted at 1:800. Purified
rat monoclonal anti-CD31 (eBioscience, San Diego, CA) was
diluted at 1:50 followed by anti-rat Alexa 647 antibody (Invitrogen,
Carlbad, CA) diluted at 1:800. Monoclonal FITC conjugated anti-
SMA (Sigma, St. Louis, MO) was diluted at 1:500. All immuno-
fluorescence described in this manuscript was detected using a Zeiss
Axiovert 200 fluorescent microscope (Thornwood, NY). Photo-
graphs were taken with an onboard monochrome AxioCam MRm
camera and colored using Adobe Photoshop (San Jose, CA).
Cell Isolation
All mice used in this study were C57BL6, predominantly male,
ages ranging from 1-25 months old (n=50). Gender comparisons
were initially conducted with 2 month old (MO) mice. As there
was gender variation in the percentage of muscle EC found in
2 MO mice, subsequent isolations for muscle groups were
conducted only in males. Graphs, statistical analysis, and error
bars were created using Microsoft Excel (Redmond, WA) by
standard deviation and student t-test.
For each FACS analysis skeletal muscles including triceps,
pectorals and all limb muscles were harvested aseptically from
multiple mice. With the exception of the analysis conducted for
each muscle group, skeletal muscles from each mouse were pooled
and treated as individual samples. Muscle was minced with
dissecting scissors into small pieces #3 mm then digested with a
final concentration of 1.2units/ml Dispase II, 2 mg/ml Collage-
nase type IV (Worthington, Lakewood, NJ) and 2 mM CaCl2 in
PBS for 45 minutes at 37uC to release mononuclear cells. Every
15 minutes samples were pipetted first with a 25 ml and then a
5 ml serological pipet to fracture clumps and dissociate mononu-
clear cells. The digestion was neutralized by adding twice the
original volume HAM’S/F10 supplemented with 15% horse
serum (all from HyClone, Logan, UT). To eliminate connective
tissue and fibers, samples were passed through 70 mm followed by
40 mm nylon cell strainers with a filter area of 3.14 mm
2 (BD
Falcon, Franklin Lakes, NJ). Without subsequent washing each
sample containing 40 ml was filtered into 50 ml standard
polypropylene conicals then centrifuged at 300 g rcf for 5 minutes
and resuspended in hemolytic buffer (155 mM NH4Cl, 10 mM
KHCO2. and 0.1 mM EDTA in H2O) for 5 minutes at room
temperature. Cells were counted, centrifuged once more and
resuspended in 1 ml PBS (HyClone, Logan, UT) then transferred
to 1.7 ml Eppendorf tubes for staining.
Flow Cytometry and Cell Sorting
For FACS muscle mononuclear cells were stained with
fluorescently conjugated monoclonal antibodies for Sca-1,
CD31, CD34 and CD45. Antibody/fluorophore combinations
used were anti-Sca-1 APC, anti-CD34 PE Cy7 (eBioscience, San
Diego, CA), ant-CD31 FITC or anti-CD31 PE, and anti-CD45
PerCP (BD Pharmingen, San Jose CA). The following PE and
FITC conjugated monoclonal antibodies were used separately on
different staining tubes from the same mouse muscle preparations:
anti-Syndecan 4 PE (BD Pharmingen, San Jose CA), anti-AC133
FITC, anti-NCAM PE and anti-CXCR4 PE (eBioscience, San
Diego, CA). Antibodies were diluted and combined in
PBS+0.3%BSA at a ratio of 600 ng of each antibody per 10
6
cells (3 ml from 200 mg/ml stock), except for Sca-1 APC which was
added at 300 ng per 10
6 cells due to its strong avidity. Single color
controls stained with 200 ng of each antibody/fluorophore were
arranged with 10
5 cells per control along with one unstained
control containing only cells. Samples and controls with antibodies
in PBS+0.3% BSA were incubated on ice in the dark for
45 minutes. Cells were then washed, centrifuged at 300 g rcf for
5 minutes and resuspended in PBS+0.3% BSA.
FACS-sorting was performed using a BD Aria equipped with
fiber optic guided solid state 488 nm, 633 nm and 407 nm diode
lasers, 11 bandpass filters and Diva software for compensation and
initial analysis. Utilizing the 488 nm blue laser the bandpass filter
range for FITC detection was 515–545 nm, 575–601 nm for PE,
675–695 nm for PerCP and 780–840 for PE Cy7. The 633 nm
red laser was used for APC detection within a 660–680 nm filter.
Potential spectral overlap between color filters and fluorophores
was corrected by software compensation of single color controls.
Initially forward side scatter-area vs. height (FSC-A vs. FSC-H)
and side scatter-area vs. height (SSC-A vs. SSC-H) parameters
were used to gate out duplets or any large granulated events that
Muscle Endothelial Cells
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cells were excluded by gating out CD45
+ cells. Subsequently
CD45
2, Sca-1
+ and CD31
+ cells were selected as muscle EC for
sorting. Positive events and gates were determined by comparing
fluorophore signal intensities between the unstained control and
each single antibody/fluorophore control. FACS-sorted cells were
collected in medium for culture, RLT buffer (Qiagen, Valencia,
CA) for reverse transcription or quantitative PCR (RT-PCR, Q-
RT-PCR) or 2% PFA for direct immunohistochemistry staining
via cytocentrifugation onto glass slides. Post sorting FACS data
analysis and graph generation was done on FlowJo v7.13
(TreeStar, Ashland, OR).
Culture and Viability
Sorted muscle EC were seeded at a density of 850 cells/cm
2 on
uncoated standard polystyrene tissue culture dishes (BD Falcon,
Franklin Lakes, NJ) using high glucose Dulbecco’s Modified
Eagle’s Medium (DMEM) supplemented with 10% fetal calf serum
(FCS), 100units/ml Penicillin with 100 mg/ml Streptomycin
(HyClone, Logan, UT) and 10 ng/ml VEGF (R&D, Minneapolis,
MN). Cultures were incubated at 37uC, 5%CO2 and 5%O2.
Media was initially changed at day three and subsequently
replaced every four days or with every passage to a new dish.
To estimate cell death within the first 24 hours of culture, fresh
muscle mononuclear cells were stained with anti-CD45 PerCP,
anti-Sca-1 APC, and anti-CD31 FITC as previously described but
with DAPI (Sigma, St. Louis, MO) at a final concentration of
10 mg/ml in PBS+0.3% BSA. Dying or injured cells resulting from
cell preparation were excluded from sorting as DAPI
+ cells
detected by the BD Aria violet 407 nm laser and 450–500 nm
filter. 1000 viable endothelial cells defined as Sca-1
+, CD31
+,
CD45
2 and DAPI negative were directly deposited into each well
of a 24 well plate by flow cytometry automated cell deposition.
The average cell death was quantified 24 hours after culture by
staining each well and supernatant with DAPI (n=4). DAPI
positive cells were counted in the supernatant as well as in the
adherent fraction on the plate.
In vitro functional assays
EC functional capabilities for vascular tube formation, ac-LDL
uptake and nitric oxide (NO) production were assayed at various
times up to 80 days in culture. For vascular tube formation cells
were seeded at a density of 26,000 cells/cm
2 on tissue culture
dishes coated with pure growth factor reduced matrigel (BD,
Franklin Lakes, NJ) and incubated overnight at 37uC, 5%CO2 and
5%O2. Controls without matrigel were seeded in parallel.
Acetylated low-density lipoprotein (ac-LDL) uptake was per-
formed by adding 10 mg/ml ac-LDL labeled with rhodamine
(Biomedical Technologies Inc, Stoughton, MA). Nitric Oxide
(NO) activity was measured using the nitric oxide synthase
detection kit by Sigma (St. Louis, MO) following manufacturer’s
protocol. NO production was blocked with 6 mMo fN v-Nitro-L-
arginine methyl ester hydrochloride (L-NAME), (Sigma, St. Louis,
MO). Samples for both assays were incubated at 37uC for a
minimum of 3 hours.
In vivo syngeneic transplant studies
Three different types of transplant studies were conducted;
cultured cells injected with matrigel, cultured cells directly injected
intramuscularly and freshly FACS-sorted cells directly injected
intramuscularly. Initially the in vivo angiogenic potential of
cultured EC was examined via the standard dorsal matrigel plug
assay modified to include matrigel plug insertion over the tibialis
anterior (TA) in parallel with direct injection of plain muscle EC
into the TA [20]. Muscle EC derived from 25 MO male C57BL6
mice were harvested at 70 days in culture for transplant with and
without reduced growth factor matrigel (BD, San Diego, CA).
1610
6 cells resuspended in 200 ml of 50% matrigel with PBS were
injected subcutaneously over the dorsum. 10
6 cells resuspended in
35 ml 75% matrigel with PBS were injected subcutaneously over
the TA. Special attention was placed to prevent insertion of the
needle in the TA muscle. 10
6 cultured EC were resuspended in
35 ml PBS and directly injected into the TA of individual mice. In
this case approximately 1 mm of the needle was inserted deep in
the muscle.
Freshly sorted EC defined as Sca-1
+, CD31
+, CD45
2 along
with Sca-1
2, CD31
2 , CD45
2 control cells were harvested from
2 MO C57BL6 mice and also transplanted via direct injection into
the TA. In this experiment DAPI was again administered to cell
preparations prior to sorting at a final concentration of 10 ng/ml
in PBS+0.3% BSA to exclude dying cells. Thus for the transplant
of freshly sorted cells only DAPI negative, e.g. viable cells, were
selected for injection. The direct transplant of freshly sorted cells
was conduced under the same conditions as cultured cells with 10
6
EC and control cells being resuspended in 35 ml PBS then directly
injected into the TA of individual mice.
For all transplants donor cells were stained with the fluorescent
membrane dye PKH26 (Sigma, St. Louis, MO) according to
manufacturers instructions. PKH26 stained cells were washed and
resuspended for transplant into 2 MO male C57BL6 mice (n=8).
All mice were sacked 14 days post injection and analyzed. Once
the dermal tissue was removed matrigel plugs were visible while
remaining attached to the TA and dorsal skin. TAs and the dorsal
plug were removed and sectioned. Euthanasia and animal
injections were in compliance with local guidelines and protocols
approved by the Institutional Animal Care and Use Committee.
Reverse Transcription PCR
RNA was extracted from cells using the Qiagen (Valencia, CA)
Rneasy kit following manufacturer’s protocol. First strand cDNA
was synthesized using the High Capacity cDNA synthesis kit from
Applied Biosystems (Foster City, CA) per manufacturer’s instruc-
tions. PCR for specific target genes was performed using the
following thermal cycling conditions, 95uC- 7 9 initial activation
followed by 94uC-30’’;57uC-30’’;72uC-45’’, for 35 cycles using the
Immomix PCR mastermix from Bioline (Randolph, MA). Primer
sequences for each respective target gene are listed in table 1.
Quantitative RT-PCR
Samples for quantitative RT-PCR were setup using the sybr
green PCR master mix from Applied Biosystems (Foster City, CA)
and primer pairs listed in table 1. Reactions were run on a ABI
7900HT PCR system. Results were analyzed using SDS 2.2
software and relative expression calculated using the comparative
Ct method. cDNA from whole muscle was used to calibrate
samples while GAPDH was used as an endogenous control. Error
bars represent the standard deviation calculated from the triplicate
analysis of each time point.
Results
Tissue staining reveals CD31
+, Sca-1
+ and CD34
+
vasculature
Muscle tissue staining for CD31 in parallel with SMA, Sca-1
and CD34 highlighted arterial, capillary and venular vessels
(figure 1). The endothelial lining was clearly distinguishable from
Muscle Endothelial Cells
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the skeletal muscle (figure 1A). CD31 specifically stained
endothelial cells in both arterial and venular vessels with no
overlap of SMA staining, which exclusively depicted vascular
smooth muscle cells (figure 1A). Capillaries while negative for
SMA were also easily distinguishable by CD31 staining. Further
staining indicated that muscle EC positive for CD31 were also
positive for Sca-1 and CD34 (figures 1B & C). Though Sca-1
+/
CD31
2 and CD34
+ /CD31
2 cells were also present in the
perivascular space, only cells positive for all three markers
composed the vascular lining of arteries, veins and capillaries of
the muscle. Sca-1
+ and CD34
+ cells negative for CD31 are
perivascular cells negative for mature endothelial markers e.g.
vWF (not shown).
Sorted Sca-1
+, CD31
+, CD34
dim and CD45
2 are skeletal
muscle derived EC
Hematopoietic cells constitute a considerable fraction within the
whole muscle mononuclear cell preparation. In addition, since
some hematopoietic cells express Sca-1, CD31 or CD34, we first
gated out CD45
+ cells to remove any hematopoietic contamina-
tion (figure 2A). Muscle EC were then sorted as a distinct Sca-1
+
and CD31
+ population that was dim for CD34. Sca-1
+,CD31
+
and CD34
dim cells comprised 30-55% of all CD45
2 mononuclear
cells isolated. 99.9% of cells sorted as Sca-1
+,CD31
+ and CD34
dim
proved positive for vWF staining indicating this phenotype
represents a pure population of EC. Side scatter analysis
(figure 2B) of our sorted population revealed larger cells express
higher levels of CD31, indicating its expression is relative to cell
Table 1. Primers
RT-PCR Primer Sequences
Target Gene Forward Primer Reverse Primer
AC133 CCA TGC AGG AGG AAG TGC TT TGC TCC ACT ACA TAG TCA ATT TGC T
c-met TTA TTC ATG GGC CGG CTT AA TGG TGA TCT TCT TTC CTG TGA CA
CD36 CAT CCA AAT GAA GAT GAG CAT AGG CCA TGC CAA GGA GCT TGA TT
CXCR-4 GCC ATG GAA CCG ATC AGT GT ACA GGT GCA GCC GGT ACT TG
Msx-1 GGC CTC TCG GCC ATT TCT TAC TGC TTC TGG CGG AAC TTG
Pax3 CGC TGT CTG TGA TCG GAA CA TCT GCT CCT GCG CTG CTT
Pax 7 GCT GCT GAA GGA CGG TCA CT TCG ATG CTG TGT TTG GCT TTC
NCAM TGC TCG TGT GTC CTC CTT GA GCT TGG CAG CAA CTG ACC AT
MyoD GCT ACC CAA GGT GGA GAT CCT GGC GGT GTC GTA GCC ATT
Myf-5 CAA GCT TTC GAG ACG CTC AAG TGT CAA AGC TGC TGT TCT TTC
Syndican 3 AAC AAA GGC CGC CAT GAA CCC CGA GTA GAG GTC GTC TAG TT
Syndican 4 CCC GGA GAG TCG ATT CGA TCC AGT TCC TTG GGC TCT GA
Flk-1 AAA GAC AAC GAG ACC CTG GTA GAA CAA TGA CAA GAA GGA GCC AGA A
Tie 1 TGT TCG TGG CCT CAA TGC TA TCG GAT ACA CAC CAA GGC TAA A
Tek GGA ACC TGA CCT CGG TGC TA CCC TGA ACC TTA TAC CGG ATG A
vWF GAT GTC CAG CTC CCC TTC CT AGG CGT TTC CGA AGT CTA CCA
Flt-1 GGT GAA GAT TTG CGA CTT TGG CCG CAT GCC TTC CTT CAG
CD34 CTT CTG CTC CGA GTG CCA TT GCC AAG ACC ATC AGC AAA CAC
Ephrin B2 TGG AGG GCC TGG ATA ACC A ACT TCG GAA CCC AGG AGA TTG
Eph B4 GAG GGC TGC GTC CTG ATG T TCT GCG CCC TTC TCA TGA TA
P-Selectin CCC TCC CCA TGG AAC CAT GCA GCT GCT GTT GTA CCC AAA
Prox 1 GCG GTC CCG GGA TTC TT GTT GCA CCA CAG AAT ATT CAA CAT C
VEGFR3 ATC GGC AAC CAT CTC AAC GT GCT TTG GCG CCT TCT ACC A
eNOS TGA TGG CGA AGC GTG TGA GGG CCT GAC ATT TCC ATG AG
GAPDH GGG AAG CCC ATC ACC ATC T GCC TCA CCC CAT TTG ATG TT
b-actin CGA GGC CCA GAG CAA GAG CAC AGC CTG GAT GGC TAC GT
Q-PCR Primer Sequences
Target Gene Forward Primer Reverse Primer
AC133 CCT CTG GTG GGC TGC TTC T CAT CTC TCC GCC GCA TTT
NCAM CAA CAT GGA GGG CAT TGT CA CGA TCC GAG TAC GTC GTC TCA
CXCR4 GCC CTC GCC TTC TTC CA CCC CGA GGA AGG CAT AGA G
Syndican 4 CCC AGG GCA GCA ACA TCTT GCC GCC CAC GAT CAG A
Ephrin B2 GGA GGA CAC GGT AGG CTA TGG CCT GGT GCG CAA CCT TCT
Eph B4 GAA GAG ACC CTG TTG AAC ACA AAA CCT GAG GGT AAG TCA CCC ATT T
VEGFR3 ATC GGC AAC CAT CTC AAC GT GCT TTG GCG CCT TCT ACC A
doi:10.1371/journal.pone.0001753.t001
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negative for ac-LDL uptake while muscle EC positive for ac-LDL
comprised only 45% of all ac-LDL
+/CD45
2 cells (figure 2C).
Further analysis confirmed sorted EC are collectively CD45
2,
Sca-1
+, CD31
+ and CD34
dim while being negative for Syndecan 4,
AC133, NCAM and CXCR4 (figure 2D).
Gender comparisons performed at 2 months of age revealed
that females have a lower percentage of muscle EC, 16% less EC
as compared to males same age (figure 3A). Due to this gender
variability we used only male mice for the duration of the study.
Similar to the endothelial staining observed in different skeletal
muscles the FACS phenotype of EC among different muscle
groups was very consistent. However, there seems to be variation
in the percentage of muscle EC not only between muscle groups
but also with age (figure 3B & C). Although due to the limited
number of individual muscle samples we did not statistically
substantiate muscle group differences, hind limb muscles appear to
have more EC vs. the upper body pectorals and triceps (figure 3B).
Figure 1. Endothelial cells of the skeletal muscle are CD31, Sca-1 and CD34 positive. Skeletal muscle tissue section staining for smooth
muscle actin (SMA), CD31, Sca-1 and CD34 highlights vascular endothelial cells. All photographs were taken at 40x except controls which are at 10x.
A, SMA Cy3 shows exclusive staining of the smooth muscles cells within veins and arteries and does not overlap with CD31 FITC staining which is
localized in the endothelial lining of vessels. B & C, CD31 FITC positive vasculature is also positive for Sca-1 Texas Red and CD34 Alexa 594. Scale
bar=50 mm.
doi:10.1371/journal.pone.0001753.g001
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+, CD31
+, CD34
dim and CD45
2 endothelial cells (EC)
begins by first gating (pink box, left dot plot) on small and low granulated cells within a SSC-A and FSC-A dot plot. CD45
+ cells are then identified and
gated out by comparing the sample (green peak) with the unstained control (red peak) to reveal a Sca-1
+ and CD31
+ population of muscle EC within
the CD45
2 population (pink bar, middle histogram). The Sca-1
+ (vertical)/CD31
+ (horizontal) endothelial population (pink oval, right dot plot) which is
dim for CD34 can then be gated for further analysis or cell sorting. B, Endothelial CD31 FITC expression correlates with cell size as FSC-A comparison
indicates larger cells (blue) express more CD31. C, 45% of EC are positive for ac-LDL rhodamine uptake (red) within the entire CD45
2 population
(green) portrayed in Sca-1 APC (vertical) and CD31 FITC (horizontal). D, The endothelial cells defined as Sca-1
+, CD31
+ and CD34
dim are
homogeneously negative for CD45 PerCP, positive for Sca-1 APC and CD31 FITC, and dim for CD34 PE Cy7 (green peaks) vs. unstained controls (red
peaks). Analysis of separate aliquots from the same muscle preparations revealed EC lack Syndecan 4 PE, AC133 FITC, NCAM PE and CXCR4 PE (green
peaks EC samples, red peaks unstained control).
doi:10.1371/journal.pone.0001753.g002
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age as the percentage of muscle EC within the CD45
2 population
decreased an average of 26% from 1 to 25 MO mice (figure 3C).
Sorted EC proliferated and expanded beyond 80 days in
culture
Initially we were unsuccessful culturing EC at atmospheric
oxygen (20% O2). Therefore we attempted to grow them at
physiological oxygen levels (5% O2). Freshly sorted muscle EC
derived individually from four 25 MO C57BL6 males were
cultured in DMEM-high glucose supplemented with 10% FCS
and 10 ng/mL of VEGF. Medium was changed after the first 2
days and every four days afterwards. Under these conditions EC
grew slowly during the first week achieving first passage after 10
days and afterwards steadily doubling every 4–6 days. EC looked
very homogenous since early culture, grew in a monolayer and
proliferated at a synchronous rate. Within 60 days in culture EC
divided between 7–12 times (figure 4A). Muscle EC grown to
subconfluency prior to passage were consistently viable beyond 80
days in culture.
Cultured cells maintain endothelial phenotype and
functional capabilities
Muscle EC tested at various times in culture maintained their
functional capabilities and phenotype. Vascular tube formation
occurred rapidly, completing within 18 hours of cells being plated
Figure 3. Muscle EC abundance between gender, muscle goups and age. A, Gender comparison of the percentage (y-axis) of EC within the
CD45
2 population between 2 MO mice (n=3). * designates p,0.05. B, The percentage of EC within the CD45
2 population among different skeletal
muscles. C, Age comparison of the percentage of EC within the CD45
2 population between 1, 12 and 24 MO mice (n=3). * designates p,0.05
between 1 vs. 12 MO mice. ** designates p,0.05 between 12 vs. 25 MO mice. P values calculated by student t-test.
doi:10.1371/journal.pone.0001753.g003
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appeared to be aligning and by 4.5 hours tube formation was
observed. Cells were also capable of ac-LDL uptake and NO
production while being positive for vWF staining even after 80
days in culture (figure 4C). Endothelial specificity of NO
production was confirmed by L-NAME inhibition and positive
staining for eNOS.
RT-PCR of freshly sorted cells confirmed the expression of
many endothelial markers such as vWF, Flk-1(VEGF-Receptor 2),
Flt-1 (Fms-like Tyrosine Kinase-1), Tie 1 and Tie 2 (Tunica
Internal Endothelial Cell Kinase 1 and 2), as well as the
endothelial associated marker CD36 [21]. Although muscle EC
express some markers associated with satellite cells such as
Syndecan 3 and CD34 they were negative for definitive myogenic
Figure 4. FACS sorted EC can be culture-expanded and preserve endothelial functions in culture. A, Growth rate comparison for muscle
EC lines derived individually from four 25 MO C57BL6 males, cultured in DMEM with 10% FCS and 10 ng/ml VEGF for 60 days. B, Vascular bundle
formation occurs rapidly within 18 hrs of cells being seeded on pure matrigel vs. controls without matrigel. Photographs were taken at 1.5 hour
intervals and after 4.5 hours left overnight in culture. C, Top panel shows endothelial specific NO production. Left, muscle EC can produce NO as
detected by green fluorescence emission of DAF-2T. Middle, NO production was inhibited by L-NAME. Right, muscle EC stained with rabbit anti-eNOS
followed by anti-rabbit Alexa 647 show strong staining in endothelial caveolae. Bottom panel shows other functional assays as well as maintenance
of vWF expression. Left, cultured muscle EC uptake ac-LDL- rhodamine (red fluorescence). Middle, skeletal muscle derived EC in culture retain vWF
expression for more than 80 days as portrayed by anti-vWF with Alexa 594. Right, 99.9% of freshly FACS-sorted muscle EC stained positive for vWF
immunoperoxidase with DAB (brown). Scale bar=50 mm.
doi:10.1371/journal.pone.0001753.g004
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PLoS ONE | www.plosone.org 9 2008 | Volume 3 | Issue 3 | e0001753markers such as Pax7 (paired box gene 7), MSX1 (msh homeobox
homolog 1), and muscle regulatory factors MyoD and Myf 5
(figure 5A) [22–25].
After 70 days in culture muscle EC maintained the
expression of major endothelial markers while remaining
negative for myogenic markers (figure 5A). Interestingly by
RT-PCR muscle EC in culture appear to upregulate markers
associated with adhesion, migration and mobilization such as c-
met (Mesenchymal epithelial transition factor), CXCR4, Pax 3
(paired box gene 3), NCAM (neural cell adhesion molecule),
Syndecan 3 and 4 [26–31]. Q-RT-PCR confirmed a significant
upregulation of NCAM (48 fold increase) and Syndecan 4 (185
fold increase) beyond 50 days in culture while AC133 was
transiently upregulated before 50 days in culture (figure 5B). In
addition, late cultured muscle EC preserved functional activities
such as vascular tube formation, ac-LDL-uptake and NO
production.
The FACS-sorted Sca-1
+, CD31
+, CD34
dim and CD45
2
population contains arterial, venular and lymphatic
endothelial cells that are maintained in culture
Although the Sca-1
+, CD31
+, CD34
dim and CD45
2 phenotype
represents a pure population of muscle EC, it is a heterogeneous
collection of arterial, venular and lymphatic EC. To determine if
selection occurs early in culture, we counted the number of cells
that de-attached or died and found that only 12.4% of sorted EC
are lost in culture within the first 24 hours of being sorted (data not
shown). Endothelial progenitor cells (EPC) from blood are
classically defined as the non-adherent cell population within the
first 48 hours of culture in endothelial cell growth medium [32].
Thus non-adherent cells were removed 48 hours after initial
plating to eliminate any EPC contamination.
To eliminate the possibility that selection of any endothelial
subtype occurs in culture we compared the expression of various
Figure 6. EC of the skeletal muscle form microvessels in matrigel injected subcutaneously over the dorsum. A–B, Tissue sections of the
matrigel plug recovered from the dorsal skin of C57BL6 mice analyzed 14 days post injection reveal microvessel formation. Staining for anti-CD31 and
anti-vWF followed with a secondary Alexa 647 antibody highlight mature vessels formed within the matrigel by injected cells (PKH26
+). C, Conjugated
FITC anti-SMA staining indicates the recruitment of endogenous smooth muscle cells in the formation of microvessels. Scale bar=50 mm.
doi:10.1371/journal.pone.0001753.g006
Figure 5. RT-PCR and Q-PCR of freshly FACS-sorted and cultured muscle EC reveals the expression of major endothelial markers,
upregulation of certain adhesion markers in culture, and arterial, venular and lymphatic heterogeneity. A, RT-PCR results of freshly
FACS-sorted and cultured EC indicates they maintain expression of common endothelial markers vWF, Flk-1 and Tie2 while lacking key myogenic
markers Pax7, MSX 1, MyoD and Myf5. B, Q-RT-PCR of adhesion markers AC133, CXCR4, NCAM, and Syndecan 4 highlights significant increases of
Syndecan 4 and NCAM expression after 50 days in culture whereas expression of AC133 decreases to baseline levels. C, RT-PCR analysis of arterial,
venular, and lymphatic markers indicates sorted muscle EC comprise a hetergenous population of all three vascular origins that are maintained in
culture. D, Q-RT-PCR of three specific arterial (Ephrin 2B), venular (EphB 4) and lymphatic (VEGFR3) markers confirms the maintenance of all three
types of EC. Q-RT-PCR values are normalized to whole muscle from the same mouse sample. Error bars for this Q-RT-PCR are present but not clearly
visible due to the standard deviations being ,1.
doi:10.1371/journal.pone.0001753.g005
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presence and maintenance of arterial, venular and lymphatic EC
throughout culture (figure 5C). Results indicated that freshly
sorted cells contain and maintain expression of the arterial marker
Ephrin B2, venular markers Eph B4 and P-Selectin, as well as
lymphatic markers Prox1 and VEGFR3 [33–36]. Q-RT-PCR of
Ephrin B2, Eph B4 and VEGFR3 confirmed the expression of
arterial, venular and lymphatic specific genes throughout culture
(figure 5D). Although, levels of Ephrin B2 mRNA (arterial specific
marker) remained steady, EphB4 (venular specific) and VEGFR3
(lymphatic specific) decreased in long-term culture.
Cultured muscle EC are angiogenic when transplanted in
vivo
We first tested the angiogenic capacity of muscle EC with the
widely used dorsal matrigel plug technique [20]. To track cells in
vivo, muscle EC were labeled with PKH26, a red fluorescent dye
that irreversible binds the cell membrane and has successfully been
used for in vivo transplantation of EC [37]. 14 days after transplant
PKH26
+ EC formed new vessels that stained positive for CD31
and vWF. PKH26
+ EC made ‘‘bonafide’’ microvessels as
endogenous smooth muscle cells, identified as SMA positive but
PKH26 negative, were seen wrapping PKH26
+ vessels (figure 6).
Figure 7. EC injected intramuscularly migrate, form new vessels and integrate with existing vasculature. Top, a montage of a region
proximal to the injection site shows the needle track in the TA muscle. Bottom, a montage of a region approximately 80 mm distal to the injection site
shows extensive migration beyond 1 mm from the needle track (white line). Montage represents an overlay of the PKH26 red fluorescence over
bright field microscopy. Formation of new vessels and incorporation into existing vasculature is highlighted by anti-vWF staining in Alexa 647
(magenta). Green arrows point to areas where PKH26
+ cells are making connections with or integrated into endogenous vessels. Scale bars=50 mm.
doi:10.1371/journal.pone.0001753.g007
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potential if transplanted back into their tissue of origin, the skeletal
muscle.
14 days after direct injection into the TA, muscle EC seemed to
have migrated beyond the needle track as new trails of PKH26
+
cells were seen distal from the needle track forming new
microvessels and incorporating into existing vasculature as indicate
by detection of PKH26
+ cells in vWF
+ vessels (figure 7). New
vessels could be distinguished from pre-existing vessels by size,
anatomic position and vessel wall thickness. The formation of new
vasculature was primarily observed along paths of migration
towards perivascular regions where transplanted EC made
connections with and incorporate into existing vasculature.
Interestingly, although PKH26
+ EC were observed integrating
and making connections with endogenous capillaries and venular
vessels, we did not observe PKH26
+ EC in major arteries. Due to
lack of antibodies specific and reactive for lymphatic vessels in
mouse skeletal muscle we were unable to determine if transplanted
EC also contribute to lymphatic vessel formation or engraftment.
To better study the in vivo migration capacity of cultured muscle
EC, PKH26 stained EC embedded in matrigel were injected
subcutaneously over the TA. As expected many PKH26
+ EC
formed new microvessels within the matrigel plug, similar to what
was seen in the dorsal matrigel plugs. Moreover, significant
migration into the muscle was observed in sections distal from the
matrigel plug (figure 8). In this transplant study, it was obvious that
PKH26
+ EC migrated at least 1 mm deep into the muscle tissue
from matrigel plug. In summary, these results consistently proved
that cultured muscle EC can form and integrate in microvessels
in vivo as vWF
+/PKH26
+ vasculature was observed in all three sets
of transplants.
Freshly FACS sorted Sca-1
+, CD31
+, CD34
dim and CD45
2
cells can from microvessels upon direct transplantation
into the skeletal muscle
To test whether such a robust angiogenic capability was an
artifact of culture conditions, freshly sorted EC (Sca-1
+, CD31
+
and CD45
2) vs. freshly sorted control cells (Sca-1
2, CD31
2 and
CD45
2) were directly injected into separate TAs of uninjured
C57BL6 mice and examined 14 days post transplant. Although we
observed that freshly sorted EC did not migrate so extensively as
cultured EC, vWF staining revealed they did form new
microvessels and incorporated into existing vasculature vs. control
cells which were not at all angiogenic (figure 9). Therefore freshly
sorted muscle EC defined as Sca-1
+, CD31
+ and CD45
2 cells are
angiogenic, mature EC. To our knowledge this is the first report of
successful transplantation of freshly FACS-sorted EC with
angiogenic capacity.
Discussion
Here we describe a new method utilizing multicolor flow
cytometry to isolate pure populations of EC from the skeletal
muscle based on the antigens Sca-1, CD34, CD31 and CD45.
Figure 8. EC injected subcutaneously in matrigel migrate into the muscle. Top, a montage of the matrigel plug shows PKH26
+ microvessels
in the matrigel plug over the TA muscle. Bottom, A montage of an area approximately 80 mm distal shows migration of PKH26
+ EC. EC invaded the TA
from the matrigel plug and formed new microvessels along their migration path and also integrated into existing vessel. Staining with anti-vWF in
Alexa 647 (magenta) highlights EC angiogenic capability within the matrigel plug and muscle. Scale bars=50 mm.
doi:10.1371/journal.pone.0001753.g008
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expression in the vasculature of skeletal muscle. Sca-1 is
predominantly a marker of hematopoietic stem cells, although it
can be expressed by other cells including EC [38–40]. CD34 is
also a marker of hematopoietic stem cells and EC [41,42]. CD31 is
expressed by EC in multiple types of tissue and has even been
previously described for EC isolation [17,19,30,43]. Though
CD31 has been widely characterized in EC from various tissues, to
our knowledge this is the first study to show CD31 expression in
EC derived from skeletal muscle. Because many of these markers
are also expressed by hematopoietic cells, we used CD45 to
eliminate hematopoietic cells that may also express Sca-1, CD31
or CD34.
FACS analysis revealed varying levels of CD31 expression based
on size, bigger EC express higher CD31 levels. Cell size may differ
between different types of microvascular EC. Also, heterogeneity
within the muscle EC population was observed by ac-LDL uptake
which stains only 45% of the Sca-1
+, CD31
+, CD34
dim and
CD45
2 cells. In addition, muscle tissue staining for Sca-1, CD31,
and CD34 confirmed these markers are expressed in arterial,
including capillaries, and venular EC. In retrospect our flow
cytometry approach does not distinguish among different EC
subtypes, however has proven very specific for only EC as the
majority of sorted cells are positive for vWF (.99.9) and other
endothelial markers. Therefore the Sca-1
+, CD31
+, CD34
dim and
CD45
2 population although free of non-endothelial cells contains
many endothelial subsets that differ in size, ac-LDL uptake and
other endothelial functions, perhaps indicating ontological or
functional differences among arterial, capillary and venular EC.
RT-PCR of arterial, venular and lymphatic genes indicates that
all three EC subtypes are present in the freshly sorted population.
Unfortunately we were unable to find antibodies applicable for
flow cytometry that prove specific for arterial, venular and
lymphatic EC. With the coming of new endothelial specific
markers it may be possible to distinguish arterial, venular and
lymphatic EC. Nonetheless changes in global muscle microvascu-
lar endothelium can be studied using this current method. For
instance, the differences observed between age and gender groups
are very interesting and intriguing. However, further studies are
needed to understand the significance of such variations.
There are many diseases associated with endothelial dysfunc-
tion. The causes and mechanisms of endothelial dysfunction are
not well understood. Oxidative stress, alterations in the insulin
signaling, and NO signaling have been associated with endothelial
dysfunction [44–48]. However, many of these studies are limited
by changes or artifacts acquired in culture. Our flow cytometry
approach offers the advantage to study freshly dissociated muscle
EC prior to any in vitro manipulation and thus we believe that this
approach is suitable and appropriate to study the molecular
mechanisms involved in endothelial dysfunction. Traditionally,
primary mouse endothelial cells are very difficult to grow in vitro
and under ordinary culture conditions (20%O2) muscle EC failed
to grow. In turn, by using culture condition closer to physiological
conditions (5%O2) we can maintain and expand this muscle EC
population for in vitro or in vivo studies.
Functional assays, staining and RT-PCR indicate muscle EC
sorted as Sca-1
+, CD31
+, CD34
dim and CD45
2 retain their
functional capabilities and phenotype even after multiple passages
inculture. Thoughc-met, CXCR4,Pax3,NCAM, Syndecan 3 and
4 were upregulated in culture, it has been previously reported that
in vitro EC upregulate such genes in response to VEGF [49,50].
Moreover, the expression of endothelial related genes vWF, Tie2
and Flk-1 remained consistently positive throughout culture.
The expression of arterial, venular and lymphatic markers was
detected in freshly FACS-sorted samples and maintained in culture
up to 70 days, indicating that all three types of endothelial cells
(arterial, venular and lymphatic) are included in our sorted starting
population and their phenotype is maintained in culture. Although
expression of VEGFR3 (a lymphaticmarker)isdrastically decreased
in late culture, we wereunable to determineif lymphatic EC arelost
in late culture due to lack of specific and reactive antibodies for
lymphatic vessels of the mouse skeletal muscle. Nonetheless, mature
endothelial markers and endothelial functions examined in our
study remained consistent from isolation to culture beyond 80 days.
Therefore sorted muscle EC can be maintained and expanded for
transplant or long term in vitro studies.
Cultured muscle EC were able to form microvessels when
transplanted subcutaneously in matrigel plugs. In addition, when
cultured EC were directly injected intramuscularly in syngeneic
mice, microvessel formation was observed as well as extensive
migration and integration into existing vessels along and beyond
the injection track. To better study the capacity of these cultured
EC to migrate within the muscle, we transplanted cultured EC
embedded in matrigel subcutaneously over the TA without
penetrating the muscle. As expected we observed formation of
microvessels in the matrigel plug but also migration of EC into the
muscle parenchyma. These cells not only migrated and made
microvessels in the perimysium and endomysium but also
integrated into existing vessels within the skeletal muscle. In
addition, we did not observe any signs of rejection or inflammation
in the transplanted muscle. Thus we report here a new route for
successful transplantation of muscle EC by direct intramuscular
injection or subcutaneous delivery with matrigel.
Figure 9. Freshly sorted EC injected intramuscularly also form
new vessels and integrate with existing vasculature vs. control
cells. A, Tissues sections from mice injected intramuscularly and
examined 14 days post injection reveals freshly sorted PKH stained EC
also have angiogenic capability. Although freshly sorted EC did not
migrate as far as cultured EC several PKH
+/vWF
+ vessels highlighted by
anti-vWF staining with Alexa 647 (magenta) were visible beyond the
point of injection. B, Contrary to the capability of freshly sorted and
cultured EC to form new vessels and integrate with existing ones,
control cells sorted as Sca-1
2, CD31
2 and CD45
2 injected under the
same conditions did not exhibit any angiogenic potential. Scale
bars=50 mm.
doi:10.1371/journal.pone.0001753.g009
Muscle Endothelial Cells
PLoS ONE | www.plosone.org 13 2008 | Volume 3 | Issue 3 | e0001753When freshly FACS-sorted cells are directly transplanted into
skeletal muscle engraftment into existing vessel and formation of
newmicro vessels was also observed. To our knowledge this is the
first report of direct transplantation of pure freshly sorted
endothelial cells with angiogenic capacity. We believe this
approach will prove to be very beneficial and advantageous for
clinical application as high number of endothelial cells from fresh
muscle (30–55% of all mononuclear muscle cells) can be obtained
for direct transplantation circumventing the need of ex vivo
expansion which is a major limitation of stem cell transplants for
therapeutic angiogenesis.
Because these cells showed tremendous angiogenic potential
and migration upon direct transplantation in uninjured skeletal
muscle we are currently studying the potential mechanism(s) of
chemoattraction. Although Sca-1 is not expressed in human cells,
all the other markers used for the isolation of mouse EC cells are
widely expressed by human cells and thus we believe this protocol
could be applied to isolate EC from human skeletal muscles.
Furthermore by making it possible to isolate pure EC from the
skeletal muscle, this method can be used to advance the study of
EC biology and role in normal and diseased muscle.
The comparison of muscle EC with other organ endothelial
cells (Table 2) reveals that muscle EC share many expression
markers with other tissue microvascular cells (e.g. dermal EC,
sinusoidal liver cells, pulmonary and kidney capillary EC) such as
CD36, Tie1, Tie2, vWF, Flt-1, CD34, Sca-1and CD31. However
muscle EC express some markers not previously reported by other
endothelial cells. Syndecan 3 is expressed in freshly sorted and
cultured muscle EC and Syndecan 4, NCAM and Pax3 are
expressed in cultured muscle EC. Thus these markers may
delineate the origin of muscle EC and may be useful to identify
and distinguish muscle derived endothelial cells from other organ
endothelial cells. However, a more extensive study of the
expression of these markers in other organ endothelial cells is
needed to determine that these markers are exclusive and
ontogenic of muscle endothelial cells.
Recently several stem cell populations from the skeletal muscles
with endothelial and myogenic potential have been characterized
[51–56]. Some of these populations, e.g. mesoangioblasts, express
immature endothelial markers and myogenic markers [51]. These
cells have been localized in the perivascular tissue. In contrast, the
endothelial population from the skeletal muscle that we describe
here expresses mature endothelial markers while lacking expres-
sion of myogenic markers. While muscle EC exhibit tremendous
angiogenic capacity upon transplantation no myogenic potential
was observed in vivo. In addition, staining for Sca-1, CD34, CD31
and SMA highlights their localization in the vessels (both arterial,
including capillaries, and venular) of the skeletal muscle. Thus
these muscle EC are clearly distinguishable from the perivascular
a.k.a. pericytes with putative myogenic potential [51,53,54].
Moreover, a recent report describes the isolation of EPC from
skeletal muscle as well as other tissues [57]. These endothelial
precursors express immature endothelial markers while lacking
expression of mature endothelial markers including CD31 (table 2).
Although EPC from cord and peripheral blood express CD31 and
other mature EC markers, they also express hematopoietic
markers such as CD45 and AC133 (table 2) [58,59].
Although we cannot rule out that our muscle EC FACS-sorted
population may contains rare endothelial precursors, the EC
population in our multicolor flow cytometry assay is defined as
CD31 positive cells and the vast majority of the freshly sorted EC
express vWFand eNOS. Furthermore, our culture method seemsto
select out EPC as we remove non-adherent cells after 48 hours of
initial culture and mature EC maintain a consistent and
T
a
b
l
e
2
.
M
u
s
c
l
e
v
s
.
o
t
h
e
r
o
r
g
a
n
d
e
r
i
v
e
d
e
n
d
o
t
h
e
l
i
a
l
c
e
l
l
(
E
C
)
g
e
n
e
e
x
p
r
e
s
s
i
o
n
.
A
C
1
3
3
c
-
m
e
t
C
D
3
6
C
X
C
R
4
P
a
x
3
P
a
x
7
N
C
A
M
S
y
n
d
e
c
a
n
3
S
y
n
d
e
c
a
n
4
F
l
k
1
T
i
e
1
T
i
e
2
v
W
F
F
l
t
-
1
C
D
3
4
S
c
a
-
1
C
D
3
1
C
D
4
5
S
o
r
t
e
d
M
u
s
c
l
e
E
C
2
2
+
2
2
2
2
+
2
+
+
+
+
+
+
+
+
2
C
u
l
t
u
r
e
d
M
u
s
c
l
e
E
C
+
+
+
+
+
2
+
+
+
+
+
+
+
+
/
2
+
+
+
2
E
P
C
-
M
u
s
c
l
e
+
[
5
7
]
+
[
5
7
]
2
[
5
7
]
2
[
5
7
]
E
P
C
-
B
l
o
o
d
+
[
6
0
]
+
[
6
1
]
+
[
6
2
]
+
[
6
1
]
+
[
6
3
]
+
[
6
0
]
+
[
6
2
]
+
[
6
1
]
+
/
2
[
5
8
]
D
e
r
m
a
l
E
C
+
[
2
1
]
+
[
6
4
]
+
[
6
4
]
+
[
6
4
]
+
[
6
4
]
+
[
6
4
]
+
[
6
4
]
2
[
6
4
]
L
i
v
e
r
S
i
n
u
s
o
i
d
E
C
+
[
2
1
]
+
[
6
5
]
+
[
6
6
]
+
[
6
7
]
+
[
6
8
]
+
[
6
7
]
+
[
4
0
]
+
[
6
7
]
P
u
l
m
o
n
a
r
y
M
a
c
r
o
v
a
s
c
u
l
a
r
E
C
2
[
2
1
]
+
[
6
5
]
+
[
6
9
]
+
[
6
6
]
+
[
6
8
]
+
[
3
9
]
P
u
l
m
o
n
a
r
y
C
a
p
i
l
l
a
r
y
E
C
+
[
2
1
]
+
[
7
0
]
+
[
7
1
]
+
[
6
6
]
+
/
2
[
6
7
]
+
[
6
7
]
+
[
3
9
]
+
[
6
7
]
S
p
l
e
e
n
S
i
n
u
s
o
i
d
E
C
+
[
2
1
]
+
[
6
7
]
2
[
6
7
]
+
[
6
7
]
K
i
d
n
e
y
G
l
o
m
e
r
u
l
a
r
a
n
d
C
a
p
i
l
l
a
r
y
E
C
+
[
2
1
]
+
[
6
5
]
+
[
6
9
]
+
[
6
6
]
+
/
2
[
6
7
]
+
[
6
8
]
+
[
6
7
]
+
[
6
7
]
+
o
r
2
i
n
d
i
c
a
t
e
s
e
x
p
r
e
s
s
i
o
n
o
f
l
i
s
t
e
d
g
e
n
e
s
(
x
-
a
x
i
s
)
r
e
l
a
t
i
v
e
t
o
e
a
c
h
E
C
t
y
p
e
(
y
-
a
x
i
s
)
.
+
/
2
i
n
d
i
c
a
t
e
s
e
x
p
r
e
s
s
i
o
n
d
i
m
i
n
i
s
h
e
s
i
n
c
u
l
t
u
r
e
o
r
h
a
s
b
e
e
n
r
e
p
o
r
t
e
d
t
o
b
e
a
n
d
n
o
t
t
o
b
e
e
x
p
r
e
s
s
e
d
.
S
o
r
t
e
d
a
n
d
C
u
l
t
u
r
e
d
E
C
e
x
p
r
e
s
s
i
o
n
i
s
b
a
s
e
d
o
n
R
T
-
P
C
R
r
e
s
u
l
t
s
p
o
r
t
r
a
y
e
d
i
n
f
i
g
u
r
e
5
.
S
o
u
r
c
e
s
f
o
r
r
e
p
o
r
t
e
d
g
e
n
e
e
x
p
r
e
s
s
i
o
n
b
y
o
t
h
e
r
o
r
g
a
n
d
e
r
i
v
e
d
E
C
a
r
e
i
n
c
l
u
d
e
d
w
i
t
h
i
n
t
h
e
b
r
a
c
k
e
t
s
.
B
l
a
n
k
s
p
a
c
e
=
e
x
p
r
e
s
s
i
o
n
h
a
s
n
o
t
b
e
e
n
r
e
p
o
r
t
e
d
.
d
o
i
:
1
0
.
1
3
7
1
/
j
o
u
r
n
a
l
.
p
o
n
e
.
0
0
0
1
7
5
3
.
t
0
0
2
Muscle Endothelial Cells
PLoS ONE | www.plosone.org 14 2008 | Volume 3 | Issue 3 | e0001753homogenous morphology, proliferation rate and phenotype
through long-term culture [32]. Thus, muscle EC described in
our method constitute a mature endothelial population derived
directly from the microvasculature of the muscle that can be
maintained in culture. We believe that our approach of first
identifying markers expressed by different muscle populations based
on their anatomic position and applying this knowledge to separate
the cell populations by flow cytometry will be useful to understand
the relationship of ‘‘bonafide’’ endothelial cells with endothelial
precursor cells or multipotent cells of the skeletal muscle.
In summary we report a highly reproducible method for sorting
skeletal muscle EC utilizing the cell surface antigens Sca-1, CD31,
CD34 and CD45. We have successfully characterized the Sca-1
+,
CD31
+, CD34
dim and CD45
2 population as functional EC from
multiple mice ages ranging from 1–25 months old. To our
knowledge this is the first report of isolation and characterization
of EC from the skeletal muscle. Furthermore this is the first report
that describes direct transplantation and subsequent vasculariza-
tion of skeletal muscle by mature EC derived from the same tissue.
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